Globe Life Inc. (NYSE:GL) Stock Position Decreased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. trimmed its stake in Globe Life Inc. (NYSE:GL - Free Report) by 92.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,025 shares of the company's stock after selling 37,120 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Globe Life were worth $320,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of GL. TrueWealth Advisors LLC raised its holdings in shares of Globe Life by 1.3% in the 3rd quarter. TrueWealth Advisors LLC now owns 13,141 shares of the company's stock worth $1,392,000 after purchasing an additional 170 shares during the period. Van ECK Associates Corp raised its holdings in Globe Life by 40.0% in the third quarter. Van ECK Associates Corp now owns 58,455 shares of the company's stock valued at $6,480,000 after buying an additional 16,703 shares during the period. Farther Finance Advisors LLC lifted its position in Globe Life by 4.8% during the third quarter. Farther Finance Advisors LLC now owns 3,607 shares of the company's stock valued at $382,000 after buying an additional 166 shares in the last quarter. US Bancorp DE grew its stake in Globe Life by 1.3% during the third quarter. US Bancorp DE now owns 36,735 shares of the company's stock worth $3,891,000 after buying an additional 470 shares during the period. Finally, First Trust Direct Indexing L.P. grew its stake in Globe Life by 39.2% during the third quarter. First Trust Direct Indexing L.P. now owns 3,439 shares of the company's stock worth $364,000 after buying an additional 968 shares during the period. Institutional investors and hedge funds own 81.61% of the company's stock.

Globe Life Stock Down 0.2 %

GL stock traded down $0.17 during mid-day trading on Monday, hitting $109.03. 583,104 shares of the company were exchanged, compared to its average volume of 1,546,811. The company has a market capitalization of $9.15 billion, a PE ratio of 9.22 and a beta of 0.81. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. Globe Life Inc. has a twelve month low of $38.95 and a twelve month high of $132.00. The firm has a fifty day simple moving average of $106.47 and a 200 day simple moving average of $93.67.

Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $3.49 EPS for the quarter, topping analysts' consensus estimates of $3.06 by $0.43. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.46 billion. During the same period last year, the firm earned $2.71 earnings per share. The company's revenue for the quarter was up 5.1% compared to the same quarter last year. On average, research analysts forecast that Globe Life Inc. will post 12.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

GL has been the topic of several recent research reports. Morgan Stanley lifted their target price on shares of Globe Life from $110.00 to $120.00 and gave the company an "equal weight" rating in a report on Thursday, October 24th. TD Cowen initiated coverage on Globe Life in a research report on Wednesday, October 9th. They issued a "buy" rating and a $150.00 price objective on the stock. Keefe, Bruyette & Woods upped their target price on Globe Life from $120.00 to $125.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 29th. Truist Financial boosted their price target on Globe Life from $90.00 to $105.00 and gave the stock a "hold" rating in a research report on Friday, October 25th. Finally, Raymond James increased their price objective on shares of Globe Life from $160.00 to $188.00 and gave the company a "strong-buy" rating in a research report on Tuesday, October 15th. Five equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Globe Life has an average rating of "Moderate Buy" and an average target price of $124.50.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.